Navigation Links
TechniKrom's Biopharmaceutical Equipment Operations to be Integrated With Asahi Kasei Medical

GLENVIEW, Ill., Feb. 17 /PRNewswire/ -- TechniKrom, Inc. and Asahi Kasei Medical Co., Ltd., who have a longstanding partnership in the commercialization of equipment for use with Planova(TM) virus removal filters, have reached agreement for the transfer of TechniKrom's biopharmaceutical business to Asahi Kasei Medical's full ownership. The integration of operations will be marked by the formation of Asahi Kasei TechniKrom, Inc., a wholly owned subsidiary of Asahi Kasei Medical, on March 1, 2009. Financial terms were not disclosed.

The combination unites two market leaders in innovation: TechniKrom in the design, manufacture, and validation of custom biopharmaceutical processing equipment, and Asahi Kasei Medical in hollow-fiber and membrane adsorption technology. The unified product portfolio will further allow TechniKrom to advance its goal of contributing to human well-being by providing the biopharmaceutical industry with an expanded, integrated toolset to both lower the cost of drug manufacturing and achieve the highest innate drug product quality. "In addition to our existing products and services that we will continue to offer, we are extremely excited about the lineup of novel bioprocess separations products that Asahi Kasei TechniKrom will introduce over the coming months," said TechniKrom President and founder, Lou Bellafiore.

Asahi Kasei Medical's current business in the bioprocess field is centered on Planova(TM) filters and filtration systems for virus removal in the production of biopharmaceuticals. "The product line synergies with TechniKrom are a natural fit. This integration allows us to more seamlessly advance the worldwide expansion of our bioprocess operations with a base for the development, production, and sale of equipment and systems in the US, the world's leading biopharmaceuticals market," said Yasuyuki Yoshida, President of Asahi Kasei Medical.

Asahi Kasei TechniKrom will be headed by the current TechniKrom management team and will continue to operate from TechniKrom's Glenview, IL facility.

About TechniKrom

Founded in 1994, TechniKrom is a privately held, diversified engineering and qualification firm that provides technologically advanced blending, synthesis, filtration and purification equipment and services to the Biopharmaceutical, Pharmaceutical, and Nutraceutical Industries worldwide. TechniKrom equipment permits the lowest cost of production and highest innate product quality, especially in cGMP regulated environments. TechniKrom promotes the implementation of Manufacturing Science in biopharmaceutical manufacturing facilities.

For more information about TechniKrom, visit:

About Asahi Kasei Group

The Asahi Kasei Group, headed by Asahi Kasei Corporation, is one of Japan's leading industrial groups, with consolidated sales of approximately US$17 billion. It provides innovative solutions based in chemistry and materials science to a diverse range of markets including fibers, chemicals, consumer products, housing, construction, electronics, and health care.

For more information about Asahi Kasei, visit:

SOURCE TechniKrom, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
2. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
3. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
4. XTL Biopharmaceuticals Announces Presentation of Novel Pre-Clinical Inhibitors of Hepatitis C at an Upcoming International Scientific Conference
5. XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain
6. Nabi Biopharmaceuticals Announces Sale of Nabi Biologics to Biotest AG
7. Keryx Biopharmaceuticals to Present at Bank of America Investment Conference
8. Morria Biopharmaceuticals Plc Announces Appointment of Dr. Rosemary Mazanet as Interim Chief Executive Officer
9. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
10. Morria Biopharmaceuticals Plc Appoints Dr. Johnson Lau and Dr. David Sidransky to Board of Directors
11. XTL Biopharmaceuticals Ltd. AGM / EGM Postponed Until October 2, 2007
Post Your Comments:
(Date:6/23/2016)... NEWPORT BEACH, Calif. , June 23, 2016 /PRNewswire/ ... offering new biological discoveries to the medical community, has ... and co-founder Matthew Nunez . "We ... provide us with the capital we need to meet ... funding will essentially provide us the runway to complete ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... exhibiting at the Pennsylvania Convention Center and will showcase its product’s latest features ... will also be presenting a scientific poster on Disrupting Clinical Trials in The ...
(Date:6/23/2016)... 22, 2016  Amgen (NASDAQ: AMGN ) ... QB3@953 life sciences incubator to accelerate the development ... laboratory space at QB3@953 was created to help high-potential ... for many early stage organizations - access to laboratory ... Amgen launched two "Amgen Golden Ticket" awards, providing each ...
(Date:6/22/2016)... 2016 Research and Markets has announced the ... to their offering. The ... $29.3 billion in 2013. The market is expected to grow at ... to 2020, increasing from $50.6 billion in 2015 to $96.6 billion ... the forecast period (2015 to 2020) are discussed. As well, new ...
Breaking Biology Technology:
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted to ... of 2015 The gross margin was 49% (27) ... operating margin was 40% (-13) Earnings per share rose ... was SEK 249.9 M (21.2) , Outlook   ... The operating margin for 2016 is estimated to exceed ...
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
(Date:3/31/2016)... Florida , March 31, 2016 ... ) ("LegacyXChange" or the "Company") LegacyXChange ... potential users of its soon to be launched online ... ( ) will also provide potential ... use of DNA technology to an industry that is ...
Breaking Biology News(10 mins):